Zhifei Biotech announced that the application for production registration of the simeglutide injection developed by Chongqing Chen'an Biopharmaceutical Co., Ltd., a holding subsidiary of the company, recently obtained a “Notice of Acceptance” issued by the State Drug Administration. The acceptance numbers are CXSS2600146 and CXSS2600147. This product is a self-developed biosimilar, suitable for blood sugar control in adult type 2 diabetics.

Zhitongcaijing · 1d ago
Zhifei Biotech announced that the application for production registration of the simeglutide injection developed by Chongqing Chen'an Biopharmaceutical Co., Ltd., a holding subsidiary of the company, recently obtained a “Notice of Acceptance” issued by the State Drug Administration. The acceptance numbers are CXSS2600146 and CXSS2600147. This product is a self-developed biosimilar, suitable for blood sugar control in adult type 2 diabetics.